NO996353L - Farmasøytiske antikløe-formuleringer som inneholder kappaagonister og metode for behandling av kløe med disse - Google Patents

Farmasøytiske antikløe-formuleringer som inneholder kappaagonister og metode for behandling av kløe med disse

Info

Publication number
NO996353L
NO996353L NO996353A NO996353A NO996353L NO 996353 L NO996353 L NO 996353L NO 996353 A NO996353 A NO 996353A NO 996353 A NO996353 A NO 996353A NO 996353 L NO996353 L NO 996353L
Authority
NO
Norway
Prior art keywords
formulations containing
pharmaceutical anti
kappa agonists
containing kappa
treating itching
Prior art date
Application number
NO996353A
Other languages
English (en)
Other versions
NO996353D0 (no
Inventor
John J Farrar
An-Chih Chang
Virendra Kumar
Wei Yuan Zhang
Alan Cowan
Original Assignee
Adolor Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/892,599 external-priority patent/US5760023A/en
Application filed by Adolor Corp filed Critical Adolor Corp
Publication of NO996353D0 publication Critical patent/NO996353D0/no
Publication of NO996353L publication Critical patent/NO996353L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Furan Compounds (AREA)
  • Pyrrole Compounds (AREA)
NO996353A 1997-07-14 1999-12-20 Farmasøytiske antikløe-formuleringer som inneholder kappaagonister og metode for behandling av kløe med disse NO996353L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/892,599 US5760023A (en) 1997-07-14 1997-07-14 Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith
US09/064,695 US5869521A (en) 1997-07-14 1998-04-22 Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith
PCT/US1998/012789 WO1999003459A1 (en) 1997-07-14 1998-06-19 Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith

Publications (2)

Publication Number Publication Date
NO996353D0 NO996353D0 (no) 1999-12-20
NO996353L true NO996353L (no) 2000-03-13

Family

ID=26744793

Family Applications (1)

Application Number Title Priority Date Filing Date
NO996353A NO996353L (no) 1997-07-14 1999-12-20 Farmasøytiske antikløe-formuleringer som inneholder kappaagonister og metode for behandling av kløe med disse

Country Status (10)

Country Link
US (3) US6004964A (no)
EP (1) EP0996434A4 (no)
JP (1) JP2003526594A (no)
BR (1) BR9810706A (no)
CA (1) CA2288828A1 (no)
IL (1) IL132363A (no)
MX (1) MXPA99011298A (no)
NO (1) NO996353L (no)
NZ (1) NZ500438A (no)
WO (1) WO1999003459A1 (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6239154B1 (en) 1996-03-08 2001-05-29 Adolor Corporation Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
US5763445A (en) * 1996-03-08 1998-06-09 Adolor Corporation Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
ES2236630T3 (es) * 1996-11-25 2005-07-16 Toray Industries, Inc. Agente antipruritico.
US6383511B1 (en) * 1999-10-25 2002-05-07 Epicept Corporation Local prevention or amelioration of pain from surgically closed wounds
US20060172007A1 (en) * 2001-05-01 2006-08-03 Nawaz Ahmad Compositions and methods for reducing vaginal pH
US20030017207A1 (en) * 2001-05-01 2003-01-23 Lin Shun Y. Compositions and methods for treating vulvovaginitis and vaginosis
US6844438B2 (en) * 2001-08-15 2005-01-18 Mclean Hospital Corporation N-substituted derivatives of morphinan and uses thereof
US6638981B2 (en) 2001-08-17 2003-10-28 Epicept Corporation Topical compositions and methods for treating pain
GB0129267D0 (en) * 2001-12-06 2002-01-23 Syngenta Ltd Fungicides
US20060105008A1 (en) * 2002-03-28 2006-05-18 Nawaz Ahmad Compositions and methods for reducing vaginal pH
AU2003282415B2 (en) * 2002-11-20 2007-10-18 Lg Electronics Inc. Recording medium having data structure for managing reproduction of data recorded thereon and recording and reproducing methods and apparatuses
GB0227558D0 (en) * 2002-11-26 2002-12-31 Syngenta Ltd Fungicides
GB0227551D0 (en) 2002-11-26 2002-12-31 Syngenta Ltd Fungicides
GB0227555D0 (en) * 2002-11-26 2002-12-31 Syngenta Ltd Fungicides
GB0227554D0 (en) * 2002-11-26 2002-12-31 Syngenta Ltd Fungicides
GB0227556D0 (en) * 2002-11-26 2002-12-31 Syngenta Ltd Fungicides
GB0312864D0 (en) * 2003-06-04 2003-07-09 Syngenta Ltd Fungicides
GB0312863D0 (en) * 2003-06-04 2003-07-09 Syngenta Ltd Fungicides
EP1736157B1 (en) * 2004-03-30 2008-11-19 Toray Industries, Inc. Morphinan derivatives as anti-itching agent
US20080119820A1 (en) 2006-09-20 2008-05-22 Phan Phillip C Methods for Delivering Volatile Anesthetics for Regional Anesthesia and/or Pain Relief
KR20080067586A (ko) * 2007-01-16 2008-07-21 에스케이에너지 주식회사 분리막을 구비하고 있는 염료감응태양전지 및 그 제조방법
EP2244737B1 (en) 2008-01-22 2019-04-10 The Board of Regents of The University of Texas System Volatile anesthetic compositions comprising extractive solvents for regional anesthesia and/or pain relief
US8987289B2 (en) 2012-12-14 2015-03-24 Trevi Therapeutics, Inc. Methods for treating pruritus
US20140179727A1 (en) 2012-12-14 2014-06-26 Trevi Therapeutics, Inc. Methods for treating pruritus
US8637538B1 (en) 2012-12-14 2014-01-28 Trevi Therapeutics, Inc. Methods for treatment of pruritis
CN103554021A (zh) * 2013-11-25 2014-02-05 中国药科大学 一类茚酮四氢异喹啉衍生物、其制备方法及医药用途
EP3558300B1 (en) * 2016-12-21 2021-11-24 Tioga Pharmaceuticals, Inc. Solid pharmaceutical formulations of asimadoline
MX2021000908A (es) 2018-07-23 2021-06-08 Trevi Therapeutics Inc Tratamiento de la tos cronica, la dificultad respiratoria y la disnea.

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4145435A (en) * 1976-11-12 1979-03-20 The Upjohn Company 2-aminocycloaliphatic amide compounds
US4466977A (en) * 1981-04-09 1984-08-21 The Upjohn Company N-[2-Amino(oxy- or thia- group-substituted-cycloaliphatic)]benzeneacetamides and -benzamide analgesics
US4360531A (en) * 1981-04-09 1982-11-23 The Upjohn Company Substituted cycloalkanes
US4359476A (en) * 1981-04-09 1982-11-16 The Upjohn Company Adjacently substituted cycloalkane-amide analgesics
US4438130A (en) * 1981-11-12 1984-03-20 The Upjohn Company Analgesic 1-oxa-, aza- and thia-spirocyclic compounds
US4663343A (en) * 1985-07-19 1987-05-05 Warner-Lambert Company Substituted naphthalenyloxy-1,2-diaminocyclohexyl amide compounds
GB8618188D0 (en) * 1986-07-25 1986-09-03 Ici Plc Diamine compounds
US4876269A (en) * 1986-09-10 1989-10-24 E. I. Du Pont De Nemours And Company Benoz-fused cycloalkane trans-1,2-diamine derivatives
MY101368A (en) * 1986-09-10 1991-09-05 Bristol Myers Squibb Pharma Company Benzo-fused cyclaolkane and oxa-and thai,cycloalkane trans-1, 2-daimine derivatives
EP0261842B1 (en) * 1986-09-17 1990-11-22 Dr. Lo. Zambeletti S.p.A. N1-acylated-(1-(phenyl or benzyl))-1,2-ethylene diamines
GB8801304D0 (en) * 1988-01-21 1988-02-17 Ici Plc Diamine compounds
US4855316A (en) * 1988-02-18 1989-08-08 Warner-Lambert Company 1,2-diamino-4,5-dimethoxycyclohexyl amide analgesic compounds
GB8804014D0 (en) * 1988-02-23 1988-03-23 Humphreys & Glasgow Ltd Synthesis gas production
KR890012970A (ko) * 1988-02-23 1989-09-20 추후보충 테트라히드로 이소퀴놀린 유도체
EP0330467A1 (en) * 1988-02-23 1989-08-30 Glaxo Group Limited Heterocyclic compounds
NZ228331A (en) * 1988-03-16 1991-10-25 Zambeletti Spa L Amine- and amido-containing heterocyclic compounds and pharmaceutical compositions
TW199890B (no) * 1988-05-23 1993-02-11 Glaxo Group Ltd
US5021413B1 (en) * 1988-08-24 1994-12-13 Sankyo Co Analgesic thiomorpholins, their preparation, and pharmaceutical compositions containing them
GB8824400D0 (en) * 1988-10-18 1988-11-23 Glaxo Group Ltd Chemical compounds
AU626949B2 (en) * 1988-12-06 1992-08-13 Warner-Lambert Company 2-amino-4 or 5-methoxycyclohexyl amides useful as analgesics
DE4034785A1 (de) * 1990-11-02 1992-05-07 Merck Patent Gmbh 1-(2-arylethyl)-pyrrolidine
GB8830219D0 (en) * 1988-12-23 1989-02-22 Zambeletti Spa L Novel compounds
US4906655A (en) * 1989-01-24 1990-03-06 Warner-Lambert Company Novel 1,2-cyclohexylaminoaryl amides useful as analgesic agents
US4965278A (en) * 1989-04-21 1990-10-23 Warner-Lambert Company 7-(substituted)amino)-8-((substituted)carbonyl)-methylamino)-1-oxaspiro[4,5]decanes as diuretics antiiflammatory, and cerebrovascular agents
EP0398720A3 (en) * 1989-05-18 1991-07-03 Glaxo Group Limited Piperazine derivatives
GB8916395D0 (en) * 1989-07-18 1989-09-06 Zambeletti Spa L Pharmaceuticals
WO1992020657A1 (en) * 1991-05-21 1992-11-26 Smithkline Beecham Farmaceutici S.P.A. 2-(pyrrolidinyl-1-methyl)-piperidine derivatives and their use as kappa-recept or agonists
ES2121988T3 (es) * 1992-01-23 1998-12-16 Toray Industries Derivado de morfinano y uso medicinal.
DE4215213A1 (de) * 1992-05-09 1993-11-11 Merck Patent Gmbh Arylacetamide
WO1994018165A1 (en) * 1993-02-12 1994-08-18 Pfizer Inc. Sulfonamide compounds as opioid k-receptor agonists
WO1995003308A1 (en) * 1993-07-23 1995-02-02 Toray Industries, Inc. Morphinan derivative and medicinal use
WO1996006078A1 (en) * 1994-08-24 1996-02-29 Pfizer Pharmaceuticals Inc. N-(2-(pyrrolidinyl-1)-1-phenylethyl)acetamides as kappa receptor antagonists
DE19523502A1 (de) * 1995-06-28 1997-01-02 Merck Patent Gmbh Kappa-Opiatagonisten für entzündliche Darmerkrankungen
US5763445A (en) * 1996-03-08 1998-06-09 Adolor Corporation Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
US5646151A (en) * 1996-03-08 1997-07-08 Adolor Corporation Kappa agonist compounds and pharmaceutical formulations thereof
US5688955A (en) * 1996-03-08 1997-11-18 Adolor Corporation Kappa agonist compounds and pharmaceutical formulations thereof
US5888494A (en) * 1996-03-12 1999-03-30 Adolor Corporation Film-forming compositions of antihyperalgesic opiates and method of treating hyperalgesic and pruritic conditions therewith
ES2236630T3 (es) * 1996-11-25 2005-07-16 Toray Industries, Inc. Agente antipruritico.
US5849762A (en) * 1997-07-14 1998-12-15 Adolor Corporation Peripherally acting anti-pruritic opiates
US5760023A (en) * 1997-07-14 1998-06-02 Adolor Corporation Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith

Also Published As

Publication number Publication date
EP0996434A4 (en) 2001-10-10
WO1999003459A1 (en) 1999-01-28
JP2003526594A (ja) 2003-09-09
EP0996434A1 (en) 2000-05-03
CA2288828A1 (en) 1999-01-28
NO996353D0 (no) 1999-12-20
US6048860A (en) 2000-04-11
US6004964A (en) 1999-12-21
US6156769A (en) 2000-12-05
MXPA99011298A (es) 2004-10-28
NZ500438A (en) 2001-11-30
IL132363A0 (en) 2001-03-19
IL132363A (en) 2004-02-19
BR9810706A (pt) 2000-08-08

Similar Documents

Publication Publication Date Title
NO996353L (no) Farmasøytiske antikløe-formuleringer som inneholder kappaagonister og metode for behandling av kløe med disse
NO996352L (no) Kappaagonistforbindelser, farmasøytiske formuleringer og metode for forhindring og behandling av kløe med disse
NO940261D0 (no) 5-Leddete heterocykler, fremgangsmaate ved fremstilling derav og legemidler som inneholder disse forbindelser
DK0622408T3 (da) Sammensætning og fremgangsmåde til fremstilling af gelatinfrie, bløde kapsler
NO20003925L (no) FremgangsmÕte og apparat for tekstbehandling
NO20016198D0 (no) Orale farmasöytiske sammensetninger som inneholder taxaner og fremgangsmåter for anvendelse av samme i behandling
EE200000480A (et) Seade ja meetod manustamise toimumise indikatsiooniks
NO974685L (no) Acetamidderivater, fremgangsmåte for fremstilling av disse, og farmasöytisk preparat inneholdende disse
NO973479L (no) Substituerte heterosykliske forbindelser, fremgangsmåte for fremstilling og farmasöytiske blandinger inneholdende samme
NO991130L (no) Modifiserte aminosyrer, farmas°ytiske preparater som inneholder disse forbindelsene og fremgangsmÕter for fremstilling derav
NO944704D0 (no) Tiazolidinderivater og farmasöytiske blandinger som inneholder disse
IS4720A (is) Aðferð og lyfjablanda til að stýra styrk lípíða
NO975987D0 (no) 4-Fenylaminotiazol-derivater, fremgangsmåte for fremstilling av disse og farmasöytiske blandinger inneholdende nevnte derivater
ZA986206B (en) Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith
NO308294B1 (no) Dimetyl-3(aryl-but-3-enyl)-aminforbindelse som farmasøytiske forbindelser og anvendelse av disse
NO20003234L (no) Oralt administrerbare ribavirindoseformer i fast form og fremgangsmÕte for fremstilling av disse
NO20012963L (no) Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler
NO20002181D0 (no) Steriliseringsinnpakning, anvendelse derav og fremgangsmÕte for sterilisering
NO953881L (no) Fremgangsmåte og anordning for spredning av stridshoder
NO20005235D0 (no) Fluidenergimaleprosess og apparat
NO975076D0 (no) Farmasöytisk preparat som inneholder tiagabinhydroklorid, og fremgangsmåte for dets fremstilling
NO930796D0 (no) Glykopeptidderivater, fremgangsmaate for deres fremstilling og farmasoeytiske midler inneholdende disse
BR9505995A (pt) Composto método para tratamentos e composição farmacêutica
NO942209L (no) Fremgangsmåte og apparat for ekspansjon av tobakk
IS4595A (is) Búnaður og aðferð við að blanda lyfjasamsetningu saman við annað efni og aðferð við að gefa lyfjablönduna inn um munn

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application